Cryopreservation of human platelets with polyvinylpyrrolidone

Transfusion
J A SmillieR Mitchell

Abstract

Fourteen polymeric compounds were assessed for their abilities to protect human platelets from injury during freezing and thawing. The effect of polymer concentration and molecular weight, cooling rate, platelet concentration, and short-term storage on platelet recovery were studied. Polyvinylpyrrolidone, average molecular weight 10,000, was found to provide the greatest degree of protection to platelets. Recoveries of platelets of from 60 to 80 per cent were achieved using a 5 per cent final concentration of polyvinylpyrrolidone and a cooling rate of 8 C per minute. Methods of freezing small aliquots of platelets and platelet concentrates were developed. The frozen-thawed platelets were viable in vitro as shown by osmotic reversal, clot retraction, and aggregation by collagen and adenosine diphosphate. The techniques described could be developed readily to facilitate the long-term storage of platelets.

Citations

Jan 1, 1992·British Journal of Haematology·J M HealN Blumberg
Aug 22, 2007·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Fernando Lopez-NeblinaLuis H Toledo-Pereyra
Jan 1, 1983·Annals of the New York Academy of Sciences·C A SchifferJ P Dutcher
Feb 25, 2015·International Journal of Pharmaceutics·Haritz GurruchagaJose Luis Pedraz
May 7, 2008·The Korean journal of laboratory medicine·Jae Hyeon LeeYong Gon Cho
Jun 1, 1986·Cryobiology·B K Kim, M G Baldini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.